The effect of lactol on treatment of irritable bowel syndrome
Phase 2
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome with diarrhea
- Registration Number
- IRCT201206179995N4
- Lead Sponsor
- For research, Kermanshah University of Medical Sciences Vice chancellor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Abdominal pain or GI discomfort for at least three months in a year and two of following symptoms: pain relief after defecation, change in frequency of defecation with the onset of symptoms, change in fecal consistency with the onset of symptoms. Exclusion criteria: severe IBS and celiac disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal pain. Timepoint: Before, four and eight weeks after trial. Method of measurement: Questionnaire and examination; 0= NA, 1= sometimes, 2= persistent, 3= severe and disabling.;Fecal consistency. Timepoint: before, four and eight weeks after trial. Method of measurement: Questionnaire and examination; 0=NA, 1=solid, 2=watery, 3= mucosal.;Change frequency of defecation. Timepoint: before, four and eight weeks after trial. Method of measurement: Questionnaire and examination; 0= without change, 1= Decrease frequency of defecation, 2= Increase frequency of defecation.
- Secondary Outcome Measures
Name Time Method Bloating. Timepoint: Before, four and eight weeks after trial. Method of measurement: Questionnaire and examination; 0= NA, 1= some times, 2= persistent, 3= severe.;Incomplete evacuation. Timepoint: Before,4 and 8 weeks after trial. Method of measurement: Questionnaire and examination; 0= NA, 1= some times, 2= often, 3= always.;Urgency. Timepoint: Before,4 and 8 weeks after trial. Method of measurement: Questionnaire and examination; 0= NA, 1= some times, 2= frequent urgency, 3= fecal incontinency.